Thomas K. Equels

2013

In 2013, Thomas K. Equels earned a total compensation of $903.2K as CEO, President, General Counsel at Hemispherx Biopharma, a 58% decrease compared to previous year.

Compensation breakdown

Bonus$12,444
Option Awards$86,826
Salary$708,644
Other$95,250
Total$903,164

Equels received $708.6K in salary, accounting for 78% of the total pay in 2013.

Equels also received $12.4K in bonus, $86.8K in option awards and $95.3K in other compensation.

Rankings

In 2013, Thomas K. Equels' compensation ranked 7,090th out of 12,286 executives tracked by ExecPay. In other words, Equels earned more than 42.3% of executives.

ClassificationRankingPercentile
All
7,090
out of 12,286
42nd
Division
Manufacturing
2,526
out of 4,612
45th
Major group
Chemicals And Allied Products
780
out of 1,466
47th
Industry group
Drugs
581
out of 1,160
50th
Industry
Biological Products, Except Diagnostic Substances
94
out of 200
53rd
Source: SEC filing on June 27, 2016.

Equels' colleagues

We found four more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2013.

2013

William Carter

Hemispherx Biopharma

Chief Executive Officer

2013

David Strayer

Hemispherx Biopharma

Chief Scientific Officer

2013

Charles Bernhardt

Hemispherx Biopharma

Chief Financial Officer

2013

Robert Dickey

Hemispherx Biopharma

Sr. Vice President

News

You may also like